Toll Brothers (NYSE:TOL – Get Rating) announced its quarterly earnings data on Wednesday. The construction company reported $2.85 EPS for the quarter, beating the consensus estimate of $1.89 by $0.96, Briefing.com reports. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.07 billion. Toll Brothers had a return on […]
Shares of Toll Brothers, Inc. (NYSE:TOL – Get Rating) were down 2.9% on Monday . The company traded as low as $64.37 and last traded at $64.46. Approximately 1,288,130 shares were traded during trading, a decline of 8% from the average daily volume of 1,406,005 shares. The stock had previously closed at $66.36. Wall Street […]
Toll Brothers (NYSE:TOL – Get Rating) will be posting its quarterly earnings results after the market closes on Tuesday, May 23rd. Analysts expect Toll Brothers to post earnings of $1.89 per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link. Toll Brothers […]
Cartenna Capital LP acquired a new stake in Toll Brothers, Inc. (NYSE:TOL – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 240,000 shares of the construction company’s stock, valued at approximately $11,981,000. Toll Brothers accounts for approximately 2.1% of Cartenna […]
500.com restated their maintains rating on shares of Kinnate Biopharma (NASDAQ:KNTE – Get Rating) in a report released on Thursday, Benzinga reports. A number of other brokerages have also commented on KNTE. Stifel Nicolaus dropped their price target on Kinnate Biopharma from $8.00 to $5.00 in a research note on Tuesday, April 18th. HC Wainwright […]